maxipenem 1000 mg/0 bočica prašak za rastvor za injekciju ili infuziju
unifarm d.o.o. lukavac - Меропенем - prašak za rastvor za injekciju ili infuziju - 1000 mg/0 bočica - jedna bočica sa praškom za rastvor za injekciju/infuziju sadrži: 1140,94 mg meropenem trihidarata, što odgovara 1000 mg meropenema
perceval s i dodaci: sizers, holders, postdilation catheter, collapsing tool i collapsing tool base
boston medical d.o.o., zagreb - ugradbena biološka valvula i odgovarajući pribor
tolnexa 20 mg/ml koncentrat za otopinu za infuziju
krka - farma d.o.o., radnička cesta 48, zagreb, hrvatska - docetaksel - koncentrat za otopinu za infuziju - 20 mg/ml - urbroj: 1 ml koncentrata za otopinu za infuziju sadrži 20 mg docetaksela
tolnexa 20 mg/1 ml koncentrat otopine za infuziju
krka farma d.o.o. sarajevo - docetaksel - koncentrat otopine za infuziju - 20 mg/1 ml - 8 ml koncentrata otopine za infuziju sadrži: 160 mg docetaksel
tolnexa 20 mg/1 ml koncentrat otopine za infuziju
krka farma d.o.o. sarajevo - docetaksel - koncentrat otopine za infuziju - 20 mg/1 ml - 4 ml koncentrata otopine za infuziju sadrži: 80 mg docetaksel
tolnexa 20 mg/1 ml koncentrat otopine za infuziju
krka farma d.o.o. sarajevo - docetaksel - koncentrat otopine za infuziju - 20 mg/1 ml - 1 ml koncentrata otopine za infuziju sadrži: 20 mg docetaksel
theraflu max plus c 1000 mg/1 kesica+ 40 mg/1 kesica+ 10 mg/1 kesica prašak za oralni rastvor
clinres farmacija d.o.o. - askorbinska kiselina, fenilefrin, paracetamol - prašak za oralni rastvor - 1000 mg/1 kesica+ 40 mg/1 kesica+ 10 mg/1 kesica - 1 kesica sa praškom za oralni rastvor sadrži: 1000 mg paracetamola 40 mg askorbinske kiseline 10 mg fenilefrinhidrohlorida
theraflu max plus c 10 mg/1 kesica+ 40 mg/1 kesica+ 1000 mg/1 kesica prašak za oralni rastvor
clinres farmacija d.o.o. - askorbinska kiselina, fenilefrin, paracetamol - prašak za oralni rastvor - 10 mg/1 kesica+ 40 mg/1 kesica+ 1000 mg/1 kesica - 1 kesica sa praškom za oralni rastvor sadrži: 1000 mg paracetamol 40 mg askorbinska kiselina 10 mg fenilefrinhidrohlorid
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.